Kesara Na-Bangchang Selected Research

ethyl 4-methoxycinnamate

1/2023	Antiproliferative and Anti-Inflammatory Activities of Deprungsith Formulation and Its Bioactive Compounds Against Mild Psoriasis and Potential of Metabolic Herb-Drug Interactions.
7/2020	In vitro cytotoxic and toxicological activities of ethanolic extract of Kaempferia galanga Linn. and its active component, ethyl-p-methoxycinnamate, against cholangiocarcinoma.
4/2020	Cytotoxicity, Cell Cycle Arrest, and Apoptosis Induction Activity of Ethyl-p-methoxycinnamate in Cholangiocarcinoma Cell.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Kesara Na-Bangchang Research Topics

Disease

47	Malaria 11/2023 - 01/2002
36	Cholangiocarcinoma 04/2024 - 09/2010
23	Falciparum Malaria (Plasmodium falciparum Malaria) 01/2023 - 01/2005
19	Neoplasms (Cancer) 01/2024 - 01/2011
16	Infections 01/2023 - 08/2009
11	Body Weight (Weight, Body) 03/2023 - 11/2004
6	Inflammation (Inflammations) 01/2022 - 06/2014
5	Cerebral Malaria 01/2022 - 05/2005
4	Vivax Malaria 02/2016 - 09/2010
3	COVID-19 06/2023 - 01/2022
3	Psoriasis (Pustulosis Palmaris et Plantaris) 04/2023 - 07/2019
3	Severe Dengue 01/2022 - 01/2017
3	Hypertension (High Blood Pressure) 08/2019 - 05/2011
2	Neoplasm Metastasis (Metastasis) 06/2023 - 09/2022
2	Pneumonia (Pneumonitis) 06/2023 - 01/2022
2	Disease Progression 03/2023 - 01/2022
2	Cytokine Release Syndrome 01/2022 - 01/2017
2	Thalassemia 04/2018 - 06/2015
2	Hemoglobinopathies 04/2018 - 06/2015
2	Reinfection 02/2017 - 06/2009
2	Wounds and Injuries (Trauma) 01/2017 - 01/2016
2	Fever (Fevers) 01/2017 - 09/2016
2	Parasitemia 09/2016 - 06/2015
2	Coinfection 12/2015 - 01/2002
1	Diabetes Mellitus 01/2023
1	Cardiotoxicity 10/2022
1	Galactorrhea 03/2022

Drug/Important Bio-Agent (IBA)

16	Antimalarials (Antimalarial Agents)IBA 02/2023 - 02/2007
15	Mefloquine (Lariam)FDA LinkGeneric 01/2023 - 01/2005
11	atractylodinIBA 03/2023 - 02/2018
11	ArtesunateIBA 01/2023 - 05/2005
9	Chloroquine (Aralen)FDA LinkGeneric 02/2016 - 01/2002
8	Proteins (Proteins, Gene)FDA Link 10/2021 - 01/2015
7	CytokinesIBA 11/2023 - 09/2010
7	EnzymesIBA 04/2020 - 03/2008
6	Biomarkers (Surrogate Marker)IBA 01/2018 - 01/2011
5	Quinine (Quinson)FDA Link 02/2022 - 06/2009
5	CadmiumIBA 08/2019 - 12/2008
5	Heme Oxygenase-1IBA 04/2018 - 10/2005
5	artemisinin (artemisinine)IBA 01/2017 - 09/2009
5	fosmidomycinIBA 09/2010 - 04/2007
4	Capsules (Microcapsules)IBA 01/2024 - 07/2021
4	Cytochrome P-450 Enzyme System (Cytochrome P450)IBA 01/2022 - 12/2015
4	artenimol (dihydroartemisinin)IBA 01/2008 - 01/2005
3	Interleukin-6 (Interleukin 6)IBA 04/2024 - 02/2021
3	ethyl 4-methoxycinnamateIBA 01/2023 - 04/2020
3	mangostinIBA 10/2022 - 01/2017
3	VaccinesIBA 09/2021 - 02/2014
3	20-hydroxy-5,8,11,14-eicosatetraenoic acidIBA 08/2019 - 05/2011
3	plumbaginIBA 11/2016 - 01/2014
3	Primaquine FDA Link 12/2015 - 10/2010
3	Clindamycin (Cleocin)FDA LinkGeneric 10/2008 - 04/2007
2	Sericins (Sericin)IBA 04/2023 - 07/2019
2	naringinIBA 04/2023 - 07/2019
2	Glucose (Dextrose)FDA LinkGeneric 01/2023 - 01/2020
2	Dimethylnitrosamine (Nitrosodimethylamine)IBA 09/2022 - 01/2012
2	andrographolideIBA 01/2022 - 01/2022
2	Cytochrome P-450 CYP1A2 (CYP1A2)IBA 01/2022 - 12/2015
2	Ivermectin (Mectizan)FDA Link 01/2022 - 01/2017
2	Cytochrome P-450 CYP2C19IBA 01/2022 - 12/2015
2	ChemokinesIBA 01/2022 - 01/2017
2	Genetic Markers (Genetic Marker)IBA 01/2021 - 11/2019
2	Member 1 Subfamily B ATP Binding Cassette TransporterIBA 04/2020 - 03/2016
2	Oxidoreductases (Dehydrogenase)IBA 01/2020 - 01/2018
2	Heme Oxygenase (Decyclizing) (Heme Oxygenase)IBA 02/2019 - 09/2010
2	AntioxidantsIBA 01/2018 - 12/2008
2	ProstaglandinsIBA 09/2016 - 03/2010
2	CytochromesIBA 12/2015 - 05/2011
2	Hemoglobins (Hemoglobin)IBA 06/2015 - 05/2015
2	Indicators and Reagents (Reagents)IBA 06/2015 - 05/2015
2	Troleandomycin (TAO)FDA Link 05/2015 - 10/2010
2	NitrosaminesIBA 01/2015 - 01/2012
2	SYBR Green IIBA 10/2011 - 01/2011
2	AntigensIBA 03/2011 - 01/2009
1	Protein Kinases (Protein Kinase)IBA 12/2023
1	MicroRNAs (MicroRNA)IBA 12/2023
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 11/2023
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 06/2023
1	Adrenal Cortex Hormones (Corticosteroids)IBA 06/2023
1	CurcuminIBA 06/2023
1	ligustilideIBA 01/2023
1	Blood Glucose (Blood Sugar)IBA 01/2023
1	Glycated Hemoglobin (Glycosylated Hemoglobin)IBA 01/2023
1	Cyclosporine (Ciclosporin)FDA LinkGeneric 01/2023
1	Hormones (Hormone)IBA 10/2022
1	11-keto-9(E),12(E)-octadecadienoic acid (KOD)IBA 10/2022
1	RNA (Ribonucleic Acid)IBA 09/2022
1	Cadherins (E-Cadherin)IBA 09/2022
1	Omeprazole (Prilosec)FDA LinkGeneric 03/2022
1	SesquiterpenesIBA 02/2022
1	tocilizumab (atlizumab)FDA Link 01/2022
1	favipiravirIBA 01/2022
1	Antiviral Agents (Antivirals)IBA 01/2022
1	Phenobarbital (Luminal)FDA Link 01/2022

Therapy/Procedure

16	Therapeutics 01/2024 - 05/2007
9	Drug Therapy (Chemotherapy) 03/2023 - 08/2009
4	Traditional Medicine (Folk Remedies) 01/2018 - 06/2014
1	Transplantation 06/2023
1	Thai Traditional Medicine 01/2023
1	Intravenous Infusions 01/2022